Cargando…

The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia

Obesity is responsible for ~90,000 cancer deaths/year, increasing cancer incidence and impairing its treatment. Obesity has also been shown to impact hematological malignancies, through as yet unknown mechanisms. Adipocytes are present in bone marrow and the microenvironments of many types of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Xia, Mittelman, Steven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046266/
https://www.ncbi.nlm.nih.gov/pubmed/24926474
http://dx.doi.org/10.3389/fped.2014.00053
_version_ 1782480261428019200
author Sheng, Xia
Mittelman, Steven D.
author_facet Sheng, Xia
Mittelman, Steven D.
author_sort Sheng, Xia
collection PubMed
description Obesity is responsible for ~90,000 cancer deaths/year, increasing cancer incidence and impairing its treatment. Obesity has also been shown to impact hematological malignancies, through as yet unknown mechanisms. Adipocytes are present in bone marrow and the microenvironments of many types of cancer, and have been found to promote cancer cell survival. In this review, we explore several ways in which obesity might cause leukemia treatment resistance. Obese patients may be at a treatment disadvantage due to altered pharmacokinetics of chemotherapy and dosage “capping” based on ideal body weight. The adipose tissue provides fuel to cancer cells in the form of amino acids and free fatty acids. Adipocytes have been shown to cause cancer cells to resist chemotherapy-induced apoptosis. In addition, obese adipose tissue is phenotypically altered, producing a milieu of pro-inflammatory adipokines and cytokines, some of which have been linked to cancer progression. Given the prevalence of obesity, understanding its role and adipose tissue in acute lymphoblastic leukemia treatment is necessary for evaluating current treatment regimen and revealing new therapeutic targets.
format Online
Article
Text
id pubmed-4046266
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-40462662014-06-12 The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia Sheng, Xia Mittelman, Steven D. Front Pediatr Pediatrics Obesity is responsible for ~90,000 cancer deaths/year, increasing cancer incidence and impairing its treatment. Obesity has also been shown to impact hematological malignancies, through as yet unknown mechanisms. Adipocytes are present in bone marrow and the microenvironments of many types of cancer, and have been found to promote cancer cell survival. In this review, we explore several ways in which obesity might cause leukemia treatment resistance. Obese patients may be at a treatment disadvantage due to altered pharmacokinetics of chemotherapy and dosage “capping” based on ideal body weight. The adipose tissue provides fuel to cancer cells in the form of amino acids and free fatty acids. Adipocytes have been shown to cause cancer cells to resist chemotherapy-induced apoptosis. In addition, obese adipose tissue is phenotypically altered, producing a milieu of pro-inflammatory adipokines and cytokines, some of which have been linked to cancer progression. Given the prevalence of obesity, understanding its role and adipose tissue in acute lymphoblastic leukemia treatment is necessary for evaluating current treatment regimen and revealing new therapeutic targets. Frontiers Media S.A. 2014-06-05 /pmc/articles/PMC4046266/ /pubmed/24926474 http://dx.doi.org/10.3389/fped.2014.00053 Text en Copyright © 2014 Sheng and Mittelman. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Sheng, Xia
Mittelman, Steven D.
The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
title The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
title_full The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
title_fullStr The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
title_full_unstemmed The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
title_short The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
title_sort role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046266/
https://www.ncbi.nlm.nih.gov/pubmed/24926474
http://dx.doi.org/10.3389/fped.2014.00053
work_keys_str_mv AT shengxia theroleofadiposetissueandobesityincausingtreatmentresistanceofacutelymphoblasticleukemia
AT mittelmanstevend theroleofadiposetissueandobesityincausingtreatmentresistanceofacutelymphoblasticleukemia
AT shengxia roleofadiposetissueandobesityincausingtreatmentresistanceofacutelymphoblasticleukemia
AT mittelmanstevend roleofadiposetissueandobesityincausingtreatmentresistanceofacutelymphoblasticleukemia